Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Listen now
Description
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer? Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000593?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
How can we provide culturally safe care for patients with schizophrenia who are members of underserved communities? Credit available for this activity expires: 4/26/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000734?ecd=bdc_podcast_libsyn_mscpedu
Published 04/29/24
Published 04/29/24
Are you screening all adults for viral hepatitis, as recommended by the Centers for Disease Control and Prevention (CDC)? Join 2 experts in a discussion of best practices.  Credit available for this activity expires: 04/25/25 Earn Credit / Learning Objectives & Disclosures: ...
Published 04/29/24